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Interoffice Memorandum 
SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7265 Fax: (662) 915-5704 
 
TO:  All School of Pharmacy Personnel 
 
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs 
 
DATE:  June 6, 2006 
 
SUBJECT: Research News (#1) 
 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi School of Pharmacy Professional 
Agreement (Rehabilitation Centers, Inc. d/b/a Millcreek), $38,062, January 1, 2006-December 31, 2006. 
2. Dr. Joseph Byrd (P.I. – Pharmacy Practice). University of Mississippi School of Pharmacy Professional 
Agreement (Mississippi State Hospital), $24,000, May 1, 2006-April 30, 2007. 
3. Dr. Joseph Byrd (P.I. – Pharmacy Practice). Contract for Residency Training Program Support, 2006 
(University of Mississippi Medical Center), $25,000, July 1, 2006-June 30, 2007. 
4. Dr. Alice Clark (P.I. – ORSP/Pharmacognosy); Dr. Gregory Tschumper, Dr. Stephen Davis, Dr. Jason 
Ritchie and Dr. Randy Watkins (Co-P.I.’s – Chemistry); Dr. Robert Doerksen (Co-P.I. – Medicinal 
Chemistry); Dr. Peter Sukanek (Co-P.I. – Chemical Engineering); and Dr. Amy Wells (Co-P.I. – Leadership 
and Counselor Education). Innovations Through Computational Sciences (Mississippi State 
University/National Science Foundation), $356,250, May 1, 2006-April 30, 2007. 
5. Dr. John Cleary (P.I. – Pharmacy Practice). Differential Gene Expression with Micafungin (Astellas Pharma 
US, Inc.), $17,400, January 23, 2006-December 31, 2007. 
6. Dr. John Cleary (P.I. – Pharmacy Practice). Pharmaceutical Company Support (Focu Bio-Inova), $860, 
October 20, 2005-September 30, 2012. 
7. Dr. Mahmoud ElSohly (P.I. – NCNPR) and Dr. Ikhlas Khan (Co-P.I. – NCNPR). Production, Analysis and 
Distribution of Cannabis, Marijuana Cigarettes and Related Materials (National Institute on Drug 
Abuse/NIH), $1,134,173, March 16, 2006-March 15, 2007. 
8. Dr. Daneel Ferreira (P.I. – Pharmacognosy). Pre-Clinical Research Equipment (Stewart and Lynda Resnick 
Revocable Trust), $23,110, April 1, 2006-March 31, 2007. 
9. Dr. Deborah Gochfeld (P.I.– NIUST/NCNPR) and Dr. Jesse Miller (Co-P.I. – NIUST/Pharmacognosy). 
Chemical Mechanisms of Disease Resistance in Hawaiian Corals (The Research Corporation of the 
University of Hawaii/NOAA), $31,288, October 1, 2005-December 31, 2006. 
10. Dr. Mark Hamann (P.I. – Pharmacognosy). Spectroscopic Analysis of Natural Products for Confirmation of 
Chemical Structure (Novascreen Biosciences Corp.), $250, October 1, 2005-September 30, 2006. 
11. Dr. Mark Hamann (P.I. – Pharmacognosy). Production of Manzamine A and Semisynthetic/Synthetic 
Derivatives for Biological Evaluation (Novartis Pharma), $8,000, October 1, 2005-September 30, 2006. 
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12. Dr. Mark Hamann (P.I. – Pharmacognosy). Production of Manzamine A and Semisynthetic/Synthetic 
Derivatives for Biological Evaluation (Novartis Pharma), $9,965, October 1, 2005-September 30, 2006. 
13. Dr. Mark Hamann (P.I. – Pharmacognosy), Dr. Larry Walker (Co-P.I. – NCNPR) and Dr. Mitch Avery 
(Co-PI – Medicinal Chemistry). Anti-AIDS Agents from Marine Organisms (National Institute of Allergy and 
Infectious Diseases) $346,497, June 1, 2006-May 31, 2007. 
14. Dr. Ikhlas Khan (P.I. – NCNPR), Dr. Troy Smillie (Co-P.I. – NCNPR) and Dr. Shabana Khan (Co-P.I. – 
NCNPR). Identification of Antiviral Compounds from Plants (Stephen F. Austin State University/Centers for 
Disease Control), $150,000, August 1, 2005-July 31, 2006. 
15. Dr. Somyajit Majumdar (P.I. – Pharmaceutics). Oral Absorption of Hesperidin (Next Pharmaceuticals, 
Inc.), $2,500, March 27, 2006-April 26, 2006. 
16. Dr. Rae Matsumoto (P.I. – Pharmacology). Cocaine, Sigma Receptors and Fra-2 (National Institute on Drug 
Abuse), $175,771, March 1, 2006-February 28, 2007. 
17. Dr. David McCaffrey (P.I. – RIPS/Pharmaceutical Marketing and Management Research Program) and Dr. 
Alicia Bouldin (P.I. – RIPS/Pharmaceutical Marketing and Management Research Program). Mississippi 
Pharmacist Compensation Survey (Mississippi Pharmacy Association), $3,000, May 15, 2006-May 14, 2008.  
18. Dr. Dale Nagle (P.I. – Pharmacognosy) and Dr. Yu-Dong Zhou (Co-P.I. – Pharmacognosy). Anticancer 
Drug Discovery that Targets Tumor Hypoxia (National Cancer Institute), $258,535, May 1, 2006-April 30, 
2007. 
19. Dr. David Pasco (P.I – NCNPR) and Dr. Ikhlas Khan (P.I. – NCNPR). Dominican Herbal Medicine: Plants 
Used for Inflammation (The New York Botanical Garden/NIH), $115,000, February 1, 2006-July 31, 2007. 
20. Dr. Ziaeddin Shariat-Madar (P.I. – Pharmacology). Plasma Kallikrein-Kinin Systems (KKS) Regulation of 
Endothelial Function (Am. Society of Hematology), $4,000, June 1, 2006-Dec. 31, 2006. 
21. Dr. Ziaeddin Shariat-Madar (P.I. – Pharmacology). Prolylcarboxypeptidase Activates Plasma Prekallikrein 
on Endothelial Cells (American Heart Association), $65,000, January 1, 2006-December 31, 2006. (Transfer 
of Year 4 from University of Michigan) 
22. Dr. Noel Wilkin (P.I. – Pharmacy Administration) and Dr. Yi Yang (Co-P.I. – Pharmacy Administration). 
End-Stage Renal Disease (ESRD) Medications Use and Costs in the Outpatient Setting (NABI 
Biopharmaceuticals), $15,000, May 1, 2006-April 30, 2007.  
23. Dr. Noel Wilkin (P.I. – Pharmacy Administration). Graduate Student Support (Roger Green and Associates), 
$4,000, May 1, 2006-June 30, 2006. 
24. Dr. Kristine Willett (P.I. – Pharmacology). Roles of CYP1 and 19 in Fundulus Steroids and PAH 
Metabolism (Natl. Institute of Environmental Health Sciences), $231,382, May 1, 2006-April 30, 2007. 
 
The following PUBLICATIONS have appeared: 
1. Sridevi Ankisetty, Hala ElSohly, Xing-Cong Li, Shabana Khan, Babu Tekwani, Troy Smillie and Larry 
Walker, “Aromatic Constituents of Uvaria grandiflora”, Journal of Natural Products, 69, 692-694 (2006).  
2. K. Bugarith, T.T. Dinh, A.J. Li, Robert Speth and S. Ritter, “Basomedial Hypothalamic Injections of 
Neuropeptide Y Conjugated to Saporin Selectively Disrupt Hypothalamic Controls of Food Intake”, 
Endocrinology, 146, 1179-1191 (2005).  
3. Amit Chaudhary and Kristine Willett, “Inhibition of Human Cytochrome CYP1 Enzymes by Flavonoids of 
St. John’s Wort”, Toxicology, 217, 194-205 (2006). 
4. Sreekhar Cheboyina, J. O’Haver and Christy Wyandt, “A Mathematical Model to Predict the Size of the 
Pellets Formed in Freeze Pelletization Techniques: Parameters Affecting Pellet Size”, Journal of 
Pharmaceutical Sciences, 95, 167-180 (2006). 
5. Y.W. Choi, S. Takamatsu, Shabana Khan, P.V. Srinivas, Daneel Ferreira, Jianping Zhao and Ikhlas 
Khan, “Schisandrene, a Dibenzocyclooctadiene Lignan from Schisandra chinensis: Structure–Antioxidant 
Activity Relationships of Dibenzocyclooctadiene Lignans”, Journal of Natural Products, 69, 356-359 (2006). 
6. Daneel Ferreira, Desmond Slade and Johannes Marias, “Flavans and Proanthocyanidins”, Flavanoids: 
Chemistry, Biochemistry and Applications, O.M. Andersen and K.R. Markham (Eds), CRC Publishers, 
London, 553-616 (2005).  
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7. Daneel Ferreira, Desmond Slade and Johannes Marias, “Bi-, Tri-, Tetra-, Penta- and Hexaflavonoids”, 
Flavanoids: Chemistry, Biochemistry and Applications, O.M. Andersen and K.R. Markham (Eds), CRC 
Publishers, London, 1101-1128 (2005). 
8. M.J. Glass, J. Huang, Robert Speth, C. Iadecola and V.M. Pickle, “Angiotensin II AT-1A Receptor 
Immunolabeling in Rat Medial Nucleus Tractus Solitarius Neurons: Subcellular Targeting and Relationships 
with Catecholamines”, Neuroscience, 130, 713-723 (2005). 
9. R. Gormann, M. Kaloga, Daneel Ferreira, Jannie Marais and H. Kolodziej, “Newbouldiosides A–C, 
Phenylethanoid Glycosides from the Stem Bark of Newbouldia laevis”, Phytochemistry, 67, 805-811 (2006). 
10. Wasala H.M.W. Herath, Julie Mikell, Amber Hale, Daneel Ferreira and Ikhlas Khan, “Microbial 
Metabolism. Part 6.1) Metabolites of 3- and 7-Hydroxyflavones”, Chem. Pharm. Bull., 54, 320-324 (2006). 
11. S.S. Hong, D.C. Moon, S.I. Lee, S.A. Bavadekar, P.N. Patil, S.G. Lalchandani, Dennis Feller and D.D. 
Miller, “Bioisosteric Phentolamine Analogs as Potent Alpha-Adrenergic Antagonists”, Bioorganic and 
Medicinal Chemistry Letters, 15, 4691-4695 (2005).  
12. J.F. Hu, Jiangnan Peng, A.B. Kazi, M. Kelly and Mark Hamann, “Bromopyrrole Alkaloids from the 
Jamaican Sponge Didiscus oxeata”, Journal of Chemical Research, 427-428 (2005). 
13. Noer Kasanah and Mark Hamann, “SPK-843 Aparts/Kaken”, Current Opinion in Investigational Drugs, 6, 
845-853 (2005). 
14. Xing-Cong Li, Hala ElSohly, Larry Walker and Alice Clark, “Phenolic Glycosides from Potalia amara”, 
Planta Medica, 71, 977-979 (2005). 
15. Xing-Cong Li, Melissa Jacob, Yuanqing Ding, Ameeta Agarwal, Troy Smillie, Shabana Khan, Dale 
Nagle, Daneel Ferreira and Alice Clark, “Capisterones A and B, which Enhance Fluconazole Activity in 
Saccharomyces cerevisiae, from the Marine Green Alga Penicillus capitatus”, Journal of Natural Products, 
69, 542-546 (2006). 
16. Johannes Marias, B. Deavours, R.A. Dixon and Daneel Ferreira, “The Stereochemistry of Flavonoids”, 
The Science of Flavanoids, E. Grotewold (Ed), Springer, 1-46 (2005). 
17. A.M.S. Mayer and Mark Hamann, “Marine Pharmacology in 2001-2002: Marine Compounds with 
Anthelmintic, Antibacterial, Anticoagulant, Antidiabetic, Antifungal, Anti-inflammatory, Antimalarial, 
Antiplatelet, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Cardiovascular, Immune 
and Nervous Systems and Other Miscellaneous Mechanisms of Action”, Comparative Biochemistry and 
Physiology, Part C 140, 265-286 (2005). 
18. Z.H. Mbwambo, M.C. Kapingu, M.J. Moshi, F. Machumi, S. Apers, P. Cos, Daneel Ferreira, Jannie 
Marais, D.V. Berghe, L. Maes, A. Vlietinick, and L. Pieters, “Antiparasitic Activity of Some Xanthones and 
Biflavonoids from the Root Bark of Garcinia livingstonei”, J. of Nat. Pro., 69, 369-372 (2006). 
19. Christopher McCurdy and S.S. Schully, “Analgesic Substances Derived from Natural Products 
(Natureceuticals)”, Life Sciences, 78, 476-484 (2005). 
20. Christopher McCurdy, K.J. Sufka, Grant Smith, J.E. Warnick and Marcelo Nieto, “Antinociceptive 
Profile of Salvinorin A, A Structurally Unique Kappa Opioid Receptor Agonist”, Pharmacology Biochemistry 
and Behavior, 83, 109-113, Web Published (2006). 
21. F.D. Mora, D.K. Jones, Prashant Desai, Akshay Patny, Mitchell Avery, Dennis Feller, Troy Smillie, Yu-
Dong Zhou and Dale Nagle, “Bioassay for the Identification of Natural Product-Based Activators of 
Peroxisome Prolierator-Activated Receptor-y (PPARy): The Marine Sponge Metaobolite Psammaplin A 
Activates PPARy and Induces Apoptosis in Human Breast Tumor Cells”, Journal of Natural Products, 69, 
547-552 (2006). 
22. Dale Nagle and Yu-Dong Zhou, “Natural Product-Based Inhibitors of Hypoxia-Inducible Factor-1 (HIF-1)”, 
Current Drug Topics, 7, 355-369 (2006). 
23. J.O. Ojwang, Yan-Hong Wang, P.R. Wyde, Nikolaus Fischer, W. Schuehly, J.R. Appleman, S. Hinds and 
C.D. Shimasaki, “A Novel Inhibitor of Respiratory Syncytial Virus Isolated from Ethnobotanicals”, Antiviral 
Research, 68, 163-172 (2005). 
24. Igor Parshikov, B. Miriyala, Kannoth Muraleedharan, Mitchell Avery and John Williamson, “Microbial 
Transformation of Artemisinin to 5-Hydroxyartemisinin by Eurotium amstelodami and Aspergillus niger”, 
Journal of Industrial Microbiology & Biotechnology, Online First DOI: 10.1007/s10295-005-0071-2 (2006). 
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25. Igor Parshikov, B. Miriyala, Kannoth Muraleedharan, A. Illendula, Mitchell Avery and John 
Williamson, “Biocatalysis of the Anti-Malarial Artemisinin by Mucor ramannianus Strains”, Pharmaceutical 
Biology, 43, 579-582 (2005). 
26. Michael Repka, Mahmoud ElSohly, Manish Munjal and Samir Ross, “Temperature Stability and 
Bioadhesive Properties of ?9-Tetrahydrocannabinol Incorporated Hydroxypropylcellulose Polymer Matrix 
Systems”, Drug Development and Industrial Pharmacy, 32, 21-32 (2006). 
27. Amit Shah, Bonnie Avery and Christy Wyandt, “Content Analysis and Stability Evaluation of Selected 
Commercial Preparations of St. John’s Wort”, Drug Development and Industrial Pharmacy, 31, 907-916 
(2005). 
28. Robert Speth, K.H. Kim, T.S. Elton and S. Simasko, “Sarcosine, Glycine Angiotensin II is a Functional AT1 
Angiotensin Receptor Antagonist”, Endocrine, 26, 83-87 (2005). 
29. R.C. Swamy, O. Kunert, W. Schuhly, F. Bucar, Daneel Ferreira, V.S. Rani, B.R. Kumar and A.V.N.A. Rao, 
“Structurally Unique Biflavonoids from Selaginella chrysocaulos and Selaginella bryopteris”, Chemistry & 
Biodiversity, 3, 405-413 (2006). 
30. Xueqing Wang, E. Williams, M.L. Haasch and Asok Dasmahapatra, “Japanese Medaka (Oryzias latipes): 
Development Model for the Study of Alcohol Teratology, Birth Defects Research (Part B), 77, 29-39 (2006).  
31. W.L. Wilson, B.P. Roques, C.L. Cortes, Robert Speth, J.W. Harding and J.W. Wright, “Roles of Brain 
Angiotensins II and III in Thirst and Sodium Appetite, Brain Research, 1060, 108-117 (2005). 
32. C.R. Yang, Y. Zhang, Melissa Jacob, Shabana Khan, Y.J. Zhang and Xing-Cong Li, “Antifungal Activity 
of C-27 Steroidal Saponins”, Antimicrobial Agents and Chemotherapy, 50, 1710-1714 (2006). 
33. S. Yous, V. Wallez, M. Belloir, D.H. Caignard, Christopher McCurdy and J.H. Poupaert, “Novel 2(3H)-
Benzothiazolones as Highly Potent and Selective Sigma-1 Receptor Ligands”, Med. Chem. Res., 14:3, 158-
168 (2005). 
 
TECHNOLOGY TRANSFER transactions: 
(In the interest of protecting confidential information, the names and titles associated with School of Pharmacy 
invention disclosures and patent applications will no longer be published until after a patent has issued.) 
Invention Disclosures Filed in FY2005-2006:   5 
Patent Applications Pending:    34 
Recent Patents Granted:     2 
o Novel Selective Algaecides for Control of Cyanochloronta, U.S. Patent # 6,949,250. Nanayakkara, 
Dhammika; Schrader, Kevin. 
o Synthesis of Epothilones and Related Analogs, U. S. Patent # 6,989,450. Avery, Mitchell. 
 
The following SPECIAL ANNOUNCEMENTS are also listed: 
• The 2006 Graduate Student Achievement Awards in Pharmacy were presented to: Erin Holmes and 
Akshay Patny. Ms. Holmes is a Pharmacy Administration Ph.D. candidate (Advisor is Dr. Dewey 
Garner) and Mr. Patny is a Medicinal Chemistry Ph.D. candidate (Advisor is Dr. Mitch Avery). 
• Dr. Ikhlas Khan was selected as a member of the Expert Advisory Committee (EAC) for Natural Health 
Products.  The Natural Health Products Directorate (NHPD) is the official regulator of natural health 
products in Canada.  The Advisory Committee “provides the Director General of the Directorate with 
expert advice on issues related to the safety, quality and efficacy of natural health products.  The EAC 
includes members from the professional and scientific communities.  Questions referred to the EAC from 
NHPD may be from a broad range of issues, but focus on scientific areas where detailed or difficult 
evaluation is required.”  Members of the Committee are appointed for a two-year term. 
• The University of Mississippi Chapter of Sigma Xi, the Scientific Research Society, hosted a Student 
Research Poster Symposium in April 2006. Sridhar Thumma a Pharmaceutics graduate student was 
awarded the Best Presentation in Chemical Sciences III for his poster “Formulation of a Delta-9-THC 
Prodrug Utilizing PEO Matrices”.  Mr. Thumma is working on a Ph.D. degree under the direction of Dr. 
Michael Repka. 
• Two of the Integrative Graduate Education and Research Traineeship (IGERT) teams made it into the top 
six finalists in the National FedEx Institute of Technology Business Plan Competition.  One of the teams 
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(AbliTech) was awarded the second runner up position and received a cash prize of $2,500. Participants 
of IGERT are centered in the Department of Medicinal Chemistry at the University of Mississippi and 
the School of Polymers and High Performance Materials at the University of Southern Mississippi. 
• Dr. John Williamson was awarded for “Dedication and Commitment in Graduate Student Recruitment” 
at the Alliance for Graduate Education in Mississippi (AGEM) Winter Symposium, January 2006 in 
Hattiesburg, Mississippi.  Dr. Williamson also participated in recent Review Panels:  NIH-NCI SBIR 
Special Emphasis Group (March 2006); NIH-NCI/NIAID Countermeasures to Nuclear Radiation 
Terrorism (June 2005); and NIH-NCI National Cooperative Drug Discovery Groups for Cancer (October 
2004). 
• Dr. Mark Hamann was selected to become a member of the Biochimica et Biophysica Acta (BBA) 
General Subjects editorial board effective July 1, 2006. 
 
Please continue to send me important research and graduate information so that I might share it with your faculty 
colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL OF PHARMACY WEB 
PAGE (www.pharmacy.olemiss.edu)!  Thank you. 
 
cc: Ms. Dabney Weems  
 Dr. Robin Buchannon, Office of Research 
